University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

University of Wisconsin-Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer’s; on track ...

Sep. 9, 2024 — Researchers tested a preclinical model for an experimental gene therapy designed to treat multiple sulfatase deficiency (MSD), a disorder that affects the brain, lungs ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

New legislation would clarify rules around value-based contracts in Medicaid, and a new model is expanding access to gene therapies, explained Adam Colborn, JD, of AMCP.

Its pipeline targets Mendelian disorders, precision oncology, and gene therapy, with four programs in late-stage ... After reviewing our model, we now forecast a slow ramp-up of sales for acoramidis ...

Their research, published in the Proceedings of the National Academy of Sciences, highlights the potential of gene therapy to ...

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

Researcher creates a groundbreaking genetic model for breast cancer, offering new insights and potential advances in ...

Wells Fargo analyst Tiago Fauth has maintained their bullish stance on TECX stock, giving a Buy rating yesterday. Tiago Fauth has given his ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...